InvestorsHub Logo

maubry

07/26/06 8:58 AM

#3742 RE: stockmasterflash #3741

We can discuss this around mid-August.
As I am involved in the financial business
arena all I can say to you that there is
DEFINATELY an underwriter and the company
name that caused IGTG to withdraw the SB-2
is a "three lettered" name institution.

Hey my source could be wrong that's the
gamble an investor takes on.

Use your head as well, why would they withdraw
the SB-2. As for the rollout of products I have
no idea where they stand today.

As always when dealing with pinkies it will continualy
be the "roll of the dice".

dlewisfl

07/26/06 2:37 PM

#3744 RE: stockmasterflash #3741

Wrong as usual, SMF. No surprise there, showing your ignorance on these message boards seems to be your strength. You claim:

"Probably a convertable debenture which is a loan that will be paid back with stock".

FACT: A CD can be paid back in either cash -or- some form of stock. In this case, if they issue stock, it will be RESTRICTED shares, so the float will not increase in the short term. Of course, the reason companies go public is to sell stock to raise cash to build the business, so this is really not that surprising (except to a putz like you).

Looks like Ingen will be signing a CD for $2M. It is not with Cornell as you speculated (either here or RB). It's uncanny how WRONG you always seem to be. LOL!! OxyView has gotten by the FDA hurdle and they are now starting to build up inventory, sales should be coming soon. That will give them revenue to help pay back some of the $2M loan. From what I heard, the audit for FY '06 is complete and the 10K is supposed to be filed the end of next week, which will open the door to the OTCBB. Things are moving forward.....